Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann–Pick Type C Disease Model Mice-Reference-Cited by-同舟云学术

Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann–Pick Type C Disease Model Mice

Published:2022-05-04 Issue:5 Volume:5 Page:2377-2388
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Nishida Takumi¹,Yokoyama Ryoma¹,Kubohira Yuto¹,Maeda Yuki¹²,Takeo Toru³,Nakagata Naomi³,Takagi Hiroki⁴,Ishikura Kandai⁴,Yanagihara Kazunori⁴,Misumi Shogo¹,Kishimoto Naoki¹,Ishitsuka Yoichi¹^ORCID,Kondo Yuki¹,Irie Tetsumi¹²,Soga Minami⁵,Era Takumi⁵,Onodera Risako¹,Higashi Taishi¹⁶^ORCID,Motoyama Keiichi¹^ORCID

Affiliation:

1. Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan

2. Program for Leading Graduate Schools “HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program”, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan

3. Center for Animal Resources and Development (CARD), Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan

4. Research Institute of Nihon Shokuhin Kako Co., Ltd., 30 Tajima, Fuji 417-8530, Shizuoka, Japan

5. Department of Cell Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan

6. Priority Organization for Innovation and Excellence, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan

Funder

Kumamoto University

Nihon Shokuhin Kako Co., Ltd.

Tsukuba Clinical Research and Development Organization

Publisher

American Chemical Society (ACS)

Subject

Biochemistry (medical),Biomedical Engineering,General Chemistry,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.2c00233

Reference50 articles.

1. Lysosomal storage disorders: The cellular impact of lysosomal dysfunction

2. Lysosomal storage disorders

3. The molecular basis of lysosomal storage diseases and their treatment

4. Astrocytes and lysosomal storage diseases

5. Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclodextrin-based tailored polyrotaxanes for highly efficient delivery of the genome-editing molecule;Carbohydrate Polymers;2024-01

2. Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment;Clinical and Translational Medicine;2023-08

3. Exploring Receptor Binding Affinities and Hepatic Cell Association of N-Acetyl-d-Galactosamine-Modified β-Cyclodextrin-Based Polyrotaxanes for Liver-Targeted Therapies;Biomacromolecules;2023-04-10

4. Experimental pharmacology: Targeting metabolic pathways;International Review of Neurobiology;2023

5. Development of Cyclodextrin-Based Materials and Their Application to Pharmaceuticals;Oleoscience;2023